Sanofi to acquire Provention Bio for $2.9 billion



Sanofi SA announced Monday that it had reached an agreement with US biopharmaceutical company Provention Bio, Inc to acquire it for $25 per share in cash, a deal worth approximately $2.9 billion.

Pre…